MIRA INFORM REPORT

 

 

Report Date :

19.05.2014

 

IDENTIFICATION DETAILS

 

Name :

RANBAXY IRELAND LIMITED

 

 

Formerly Known As :

RIMA PHARMACEUTICALS LIMITED

 

 

Registered Office :

Spafield, Cork Road, Cashel 142821

 

 

Country :

Ireland

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

12.06.1980

 

 

Com. Reg. No.:

IE075951

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Manufacturer of Pharmaceutical 

 

 

No of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

Ireland

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

C2

Very High Risk

 

D

 


 

IRELAND - ECONOMIC OVERVIEW

 

Ireland is a small, modern, trade-dependent economy. Ireland was among the initial group of 12 EU nations that began circulating the euro on 1 January 2002. GDP growth averaged 6% in 1995-2007, but economic activity has dropped sharply since the onset of the world financial crisis. Ireland entered into a recession in 2008 for the first time in more than a decade, with the subsequent collapse of its domestic property market and construction industry. Property prices rose more rapidly in Ireland in the decade up to 2007 than in any other developed economy. Since their 2007 peak, average house prices have fallen 47%. In the wake of the collapse of the construction sector and the downturn in consumer spending and business investment, the export sector, dominated by foreign multinationals, has become an even more important component of Ireland's economy. Agriculture, once the most important sector, is now dwarfed by industry and services. In 2008 the former COWEN government moved to guarantee all bank deposits, recapitalize the banking system, and establish partly-public venture capital funds in response to the country's economic downturn. In 2009, in continued efforts to stabilize the banking sector, the Irish Government established the National Asset Management Agency (NAMA) to acquire problem commercial property and development loans from Irish banks. Faced with sharply reduced revenues and a burgeoning budget deficit, the Irish Government introduced the first in a series of draconian budgets in 2009. In addition to across-the-board cuts in spending, the 2009 budget included wage reductions for all public servants. These measures were not sufficient to stabilize Ireland’s public finances. In 2010, the budget deficit reached 32.4% of GDP - the world's largest deficit, as a percentage of GDP - because of additional government support for the country’s deeply troubled banking sector. In late 2010, the former COWEN government agreed to a $92 billion loan package from the EU and IMF to help Dublin recapitalize Ireland’s fragile banking sector and avoid defaulting on its sovereign debt. Since entering office in March 2011, the new KENNY government has intensified austerity measures to try to meet the deficit targets under Ireland's EU-IMF program. Ireland has grown slowly since 2011, but managed to reduce the budget deficit to 7.2% of GDP in 2013. In late 2013, Ireland formally exited its EU-IMF bailout program, benefiting from its strict adherence to deficit-reduction targets and success in refinancing a large amount of banking-related debt.

 

Source : CIA

 

 


REGISTERED NAME & COMPANY SUMMARY

 

Company Name:

RANBAXY IRELAND LIMITED

Limited Company

Company Number:

IE075951

 

Company Summary

Registered Address

SPAFIELD

CORK ROAD

CASHEL

142821

Trading Address

SPAFIELD

CORK ROAD

CASHEL

CO TIPPERARY

142821

Website Address

-

Telephone Number

06261206

Fax Number

TPS

No

FPS

No

Incorporation Date

12/06/1980

 

Previous Name

RIMA PHARMACEUTICALS LIMITED

Type

Other

 

FTSE Index

-

Date of Change

-

Filing Date of Accounts

-

Currency

EUR

 

DIRECTORS/MANAGEMENT

 

Total Current Directors

3

Total Current Secretaries

1

Total Previous Directors / Company Secretaries

17

 

Current Directors

Name

ASHWANI KUMAR MALHOTRA

Date of Birth

30/04/1956

Officers Title

 

Nationality

 

Present Appointments

1

Function

Director

Appointment Date

07/03/2011

 

 

Address

HOUSE NO 1513, SECTOR 18-D, CHANDIGARH - 160018, INDIA

Other Actions

View Director Report

 

 

Disqualified

 

Disqualified End Date

 

Disqualification Exception

No

 

 

 

Name

VICKRAMAN SATTANTHAN

Date of Birth

30/07/1963

Officers Title

 

Nationality

 

Present Appointments

1

Function

Director

Appointment Date

26/03/2012

 

 

Address

BUILDING 4, CHISWICK PARK, 566 CHISWICK HIGH ROAD, LONDON W4 5YE UNITED KINGDOM

Other Actions

View Director Report

 

 

Disqualified

 

Disqualified End Date

 

Disqualification Exception

No

 

 

 

Name

NEERAJ SHARMA

Date of Birth

29/05/1972

Officers Title

 

Nationality

 

Present Appointments

1

Function

Director

Appointment Date

29/01/2013

 

 

Address

VIA RENONCINO 1117, BASIGLIO (MI) 20080 MILAN ITALY

Other Actions

View Director Report

 

 

Disqualified

 

Disqualified End Date

 

Disqualification Exception

No

 

 

 

Current Company Secretary

Name

SEAMUS MOLONEY

Date of Birth

11/06/1971

Officers Title

 

Nationality

 

Present Appointments

1

Function

Company Secretary

Appointment Date

18/05/2004

 

 

Address

MORTLESTOWN, CAHIR, CO.TIPPERARY

 

Previous Director/Company Secretaries

Name

Current Directorships

Previous Directorships

SHINA LAW

0

1

NORMAN NICHOL

0

1

PUSH BINDRA

0

1

SATTANATHAN VIKRAMAN

0

1

DEBASHIS DAS GUPTA

0

1

PETER BUREMA

0

1

SANDEEP PURI

0

1

PRADEEP CHAUHAW

0

1

MICHAEL HOLOHAN

0

2

MICHAEL HOLOHAN

0

2

. KASSAM. RIZANALI NOORALI

0

1

MASUMALI NOORALI KASSAM

0

1

OMESH SETHI

0

1

SANDEEP MEHANDROO

0

1

VINOD MAHINDRA

0

1

BRIAN TEMPEST

0

1

ARUN SAWHNEY

0

1

 

NEGATIVE INFORMATION

 

CJ

 

Total Number of Exact CJs -

0

Total Value of Exact CJs -

€0

Total Number of Possible CJs -

0

Total Value of Possible CJs -

€0

Total Number of Satisfied CJs -

0

Total Value of Satisfied CJs -

€0

 

Possible CJ Details

There are no possible CJ details

Writ Details

 

Mortgage Details

 

Mortgage Type:

CONDITIONS FOR MULTI ACCOUNT CLIENTS.

Date Charge Created:

29/01/97

 

 

Date Charge Registered:

13/02/97

 

 

Date Charge Satisfied:

08/12/11

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

AMERICAN EXPRESS BANK LTD

Amount Secured:

0

Details:

ALL PRESENT AND FUTURE INDEBTEDNESS OF THE COMPANY WITH INTEREST UNDER SPECIFIC AGREEMENT(S)

 

Mortgage Type:

DEED OF CHATTEL MORTGAGE.

Date Charge Created:

09/10/95

 

 

Date Charge Registered:

12/10/95

 

 

Date Charge Satisfied:

08/12/11

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

ICC BANK PLC

Amount Secured:

0

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

A CHARGE.

Date Charge Created:

15/12/89

 

 

Date Charge Registered:

03/01/90

 

 

Date Charge Satisfied:

08/12/11

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

ALLIED IRISH BANKS PLC

Amount Secured:

0

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

DEED OF CHATTEL MORTGAGE.

Date Charge Created:

15/09/88

 

 

Date Charge Registered:

19/09/88

 

 

Date Charge Satisfied:

08/12/11

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

INDUSTRIAL CREDIT CORPORATION PLC

Amount Secured:

0

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

LETTER OF LIEN AND SET-OFF.

Date Charge Created:

25/02/87

 

 

Date Charge Registered:

09/03/87

 

 

Date Charge Satisfied:

08/12/11

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

ALLIED IRISH BANKS PLC

Amount Secured:

0

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

DEED OF MORTGAGE.

Date Charge Created:

20/01/86

 

 

Date Charge Registered:

25/03/86

 

 

Date Charge Satisfied:

08/12/11

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

INDUSTRIAL CREDIT CORPORATION PLC

Amount Secured:

0

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

DEED OF CHATTEL MORTGAGE.

Date Charge Created:

02/12/85

 

 

Date Charge Registered:

10/12/85

 

 

Date Charge Satisfied:

08/12/11

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

INDUSTRIAL CREDIT CORPORATION PLC

Amount Secured:

0

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

DEED OF CHATTEL MORTGAGE.

Date Charge Created:

23/05/85

 

 

Date Charge Registered:

07/06/85

 

 

Date Charge Satisfied:

08/12/11

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

INDUSTRIAL CREDIT CORPORATION PLC

Amount Secured:

 

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

A DEED OF CHARGE.

Date Charge Created:

31/01/85

 

 

Date Charge Registered:

15/02/85

 

 

Date Charge Satisfied:

08/12/11

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

INDUSTRIAL CREDIT CORPORATION PLC

Amount Secured:

 

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

A DEBENTURE.

Date Charge Created:

20/08/84

 

 

Date Charge Registered:

03/09/84

 

 

Date Charge Satisfied:

08/12/11

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

ALLIED IRISH BANKS PLC

Amount Secured:

 

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

A DEED OF DEBENTURE.

Date Charge Created:

03/08/84

 

 

Date Charge Registered:

15/08/84

 

 

Date Charge Satisfied:

08/12/11

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

INDUSTRIAL CREDIT CORPORATION PLC

Amount Secured:

 

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

SHARE & SHARE CAPITAL INFORMATION

 

Share Capital

€7,111,465

SIC07

21100

 

Top 20 Shareholders

Name

Currency

Share Count

Share Type

Nominal Value

RANBAXY (NETHERLANDS) BV

EUR

5,644,020

ORDINARY

1.26

 

PAYMENT INFORMATION

 

Company DBT

DBT -

Industry DBT 10

 

 

Payment Trend

Stable

Within terms

Within terms 91+ Days

 

Within Terms

0-30 Days

31-60 Days

61-90 Days

91+ Days

 

Creditor Details

 

 

Total Number

Total Value

Trade Creditors

0

-

 

No Creditor Data

 

Trade Debtors / Bad Debt Detail

 

 

Total Number of Documented Trade

Total Value of Documented Trade

Trade Debtors

-

-

 

No Debtor Data

 

Average Invoice Value

n/a

Invoices available

n/a

Paid

n/a

Outstanding

n/a

 

Trade Payment Data is information that we collect from selected third party partners who send us information about their whole sales ledger.

 

 

Within Terms

0-30 Days

31-60 Days

61-90 Days

91+ Days

Paid

 

 

 

 

 

Outstanding

 

 

 

 

 

 

GROUP STRUCTURE & AFFILIATED COMPANIES

 

Statistics

 

Group

11 companies

Linkages

25 companies

Countries

In 8 countries

 

Summary

 

Holding Company

-

Ownership Status

Intermediately Owned

Ultimate Holding Company

DAIICHI SANKYO CO LTD

 

Group structure

 

Company Name

Registered Number

Latest Key Financials

Consol. Accounts

Rating

Limit

Turnover

DAIICHI SANKYO CO LTD

N/A

-

-

-

-

 

DAIICHI SANKYO EUROPE...

HRB 6262

31.03.2013

Y

100

€15,000,000

€767,776,207

DAIICHI SANKYO IRELA...

IE462208

31.03.2013

N

86

€25,000

€5,304,000

DAIICHI SANKYO UK LI...

01998736

31.03.2013

N

94

£490,000

£10,431,000

DAIICHI SANKYO DEVELOP...

02805907

31.03.2013

N

97

£455,000

£22,439,000

RANBAXY LABORATORIES

N/A

31.12.2013

-

40

€565,000

€163,448,447

RANBAXY (NETHERLANDS...

33254757

31.12.2012

N

82

€9,500,000

 

RANBAXY HOLDINGS (...

03062051

31.12.2012

N

95

£100,000

 

RANBAXY EUROPE LI...

03592373

31.12.2012

N

96

£100,000

£6,883,345

RANBAXY IRELAND LI...

IE075951

31.12.2012

N

95

€385,000

€36,708,991

RANBAXY (U.K.) LIM...

02992795

31.12.2012

N

88

£175,000

£23,951,769

 

Other Linked companies

 

Name

 

Number

Latest Key Financials

Rating

Limit

Turnover

DAIICHI SANKYO

 

 

31.03.2013

85

€50,000,000

€8,556,513,090

SANKYO

 

 

31.03.2013

70

€50,000,000

€893,079,172

DAIICHI SANKYO FRANCE SAS

 

382677144

31.03.2013

81

€950,000

€139,888,032

DAIICHI SANKYO REAL ESTATE GMBH

 

HRB 4128

31.03.2013

84

€150,000

€1,343,338

U3 PHARMA GMBH

 

HRB 177122

31.03.2013

56

€235,000

€10,000,559

DAIICHI FINE CHEMICAL EUROPE GMBH

 

HRB 24383

31.03.2009

N/R

-

 

DAIICHI SANKYO ALTKIRCH SARL

 

305506412

31.03.2011

57

€75,000

€6,304,343

RANBAXY ITALIA S.P.A.

 

MI1787791

31.12.2012

view rating

view limit

€27,393,391

DAIICHI SANKYO DEUTSCHLAND GMBH

 

HRB 7243

31.12.2006

76

€50,000

€32,385,540

LAPHARMA GMBH

 

HRB 96373

31.03.2010

N/R

-

 

DAIICHI SANKYO NEDERLAND B.V.

 

34095893

31.03.2013

50

€300,000

€7,602,758

DAIICHI

 

 

-

N/R

-

 

RANBAXY BELGIUM BVBA

 

428546790

31.12.2012

74

€70,000

€28,088

DAIICHI SANKYO ESPAÑA

 

456957

31.03.2011

80

€0

€58,101,977

DAIICHI SANKYO REAL ESTATE GMBH & CO. OBJECT MUNICH KG

 

HRA 1919

31.03.2012

N/R

-

€3,708,620

O.H.M. LABORATORIES, INC

 

 

-

70

$13,300

$1,329,000

PHARMAFORCE, INC

 

 

-

27

$17,600

$994,000

PLEXXIKON INC

 

 

-

85

$37,700

$2,218,000

ROXRO PHARMA, INC

 

 

-

75

$14,000

$1,402,000

SANKYO PHARMA INC

 

 

-

18

$13,200

 

 

FINANCIAL INFORMATION

 

Profit & Loss

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Weeks

52

(%)

52

(%)

52

(%)

52

(%)

52

Currency

EUR

(%)

EUR

(%)

EUR

(%)

EUR

(%)

EUR

Consolidated A/cs

N

(%)

N

(%)

N

(%)

N

(%)

N

Turnover

€36,708,991

8.7%

€33,785,253

8.3%

€31,207,696

15.6%

€26,994,607

-32.2%

€39,786,884

Export

-

-

-

-

-

-

-

-

-

Cost of Sales

€22,609,549

5.2%

€21,483,647

8.1%

€19,869,496

18.4%

€16,782,370

-33.2%

€25,123,907

Gross Profit

€14,099,442

14.6%

€12,301,606

8.5%

€11,338,200

11%

€10,212,237

-30.4%

€14,662,977

Wages & Salaries

€3,528,990

5.4%

€3,347,881

2.2%

€3,274,588

5.2%

€3,111,565

4.3%

€2,984,590

Directors Emoluments

-

-

-

-

-

-

-

-

-

Operating Profit

€2,234,552

130.9%

€967,905

36.3%

€709,912

-14.3%

€828,420

-62.9%

€2,229,994

Depreciation

€519,388

-0.6%

€522,308

0.1%

€521,969

-6.8%

€559,820

0%

€559,751

Audit Fees

€36,000

2.9%

€35,000

-49.7%

€69,607

45.4%

€47,880

-7.9%

€51,995

Interest Payments

-

-

-

-

-

-

-

-

-

Pre Tax Profit

€2,286,769

124.4%

€1,018,857

35.1%

€754,237

-12.4%

€861,124

-63.3%

€2,344,997

Taxation

-€293,255

-82.6%

-€160,603

-48.2%

-€108,361

31.7%

-€158,629

45.8%

-€292,832

Profit After Tax

€1,993,514

132.3%

€858,254

32.9%

€645,876

-8.1%

€702,495

-65.8%

€2,052,165

Dividends Payable

-

-

-

-100%

€2,500,000

-50%

€5,000,000

-28.6%

€7,000,000

Retained Profit

€1,993,514

132.3%

€858,254

146.3%

-€1,854,124

56.9%

-€4,297,505

13.1%

-€4,947,835

 

Balance Sheet

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Tangible Assets

€7,828,044

12.3%

€6,968,914

-0.7%

€7,021,159

-2.2%

€7,182,151

-28.5%

€10,042,726

Intangible Assets

0

-

0

-100%

€128,896

-50%

€257,740

-40.7%

€434,701

Total Fixed Assets

€7,828,044

12.3%

€6,968,914

-2.5%

€7,150,055

-3.9%

€7,439,891

-29%

€10,477,427

Stock

€3,931,256

88.8%

€2,082,029

-5.9%

€2,211,806

-24.1%

€2,914,340

45.4%

€2,004,753

Trade Debtors

€4,317,615

16.7%

€3,699,185

4.2%

€3,548,776

-4.3%

€3,706,826

192.2%

€1,268,702

Cash

€4,802,033

87.3%

€2,563,246

-13%

€2,945,095

119.5%

€1,341,746

-61.2%

€3,459,075

Other Debtors

€5,503,400

73.2%

€3,177,482

44.2%

€2,202,974

-67.6%

€6,792,595

-42.5%

€11,817,675

Miscellaneous Current Assets

0

-

0

-

0

-

0

-

0

Total Current Assets

€18,554,304

61%

€11,521,942

5.6%

€10,908,651

-26.1%

€14,755,507

-20.5%

€18,550,205

Trade Creditors

€497,473

25.7%

€395,638

31.6%

€300,746

10%

€273,449

45.1%

€188,415

Bank Loans & Overdrafts

€1,883

-

0

-

0

-

0

-

0

Other Short Term Finance

€7,815,191

203%

€2,579,080

-4.6%

€2,704,782

-53%

€5,760,240

-10.4%

€6,428,427

Miscellaneous Current Liabilities

€1,913,650

62.2%

€1,179,573

-24.6%

€1,563,928

94.7%

€803,121

113%

€377,099

Total Current Liabilities

€10,228,197

146.2%

€4,154,291

-9.1%

€4,569,456

-33.2%

€6,836,810

-2.2%

€6,993,941

Bank Loans & Overdrafts and LTL

€304,668

8.8%

€280,081

3%

€272,017

1.4%

€268,223

37.3%

€195,325

Other Long Term Finance

0

-

0

-

0

-

0

-

0

Total Long Term Liabilities

€302,785

8.1%

€280,081

3%

€272,017

1.4%

€268,223

37.3%

€195,325

.

Capital & Reserves

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Called Up Share Capital

€7,111,465

-

€7,111,465

-

€7,111,465

-

€7,111,465

-

€7,111,465

P & L Account Reserve

€6,984,308

39.9%

€4,990,794

20.8%

€4,132,540

-31%

€5,986,664

-41.8%

€10,284,169

Revaluation Reserve

€1,294,853

-12.2%

€1,474,472

-

€1,474,472

-

€1,474,472

-62.3%

€3,905,960

Sundry Reserves

€460,740

-4%

€479,753

-3.8%

€498,756

-3.7%

€517,764

-3.5%

€536,772

Shareholder Funds

€15,851,366

12.8%

€14,056,484

6.3%

€13,217,233

-12.4%

€15,090,365

-30.9%

€21,838,366

 

Other Financial Items

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Net Worth

€15,851,366

12.8%

€14,056,484

7.4%

€13,088,337

-11.8%

€14,832,625

-30.7%

€21,403,665

Working Capital

€8,326,107

13%

€7,367,651

16.2%

€6,339,195

-19.9%

€7,918,697

-31.5%

€11,556,264

Total Assets

€26,382,348

42.7%

€18,490,856

2.4%

€18,058,706

-18.6%

€22,195,398

-23.5%

€29,027,632

Total Liabilities

€10,530,982

137.5%

€4,434,372

-8.4%

€4,841,473

-31.9%

€7,105,033

-1.2%

€7,189,266

Net Assets

€15,851,366

12.8%

€14,056,484

6.3%

€13,217,233

-12.4%

€15,090,365

-30.9%

€21,838,366

 

Cash Flow

 

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Net Cashflow from Operations

€3,901,170

999.9%

€211,860

-95%

€4,223,528

59.6%

€2,647,146

-67.2%

€8,062,726

Net Cashflow before Financing

€2,236,904

685.8%

-€381,849

-123.8%

€1,603,349

175.7%

-€2,117,329

-999.9%

-€138,416

Net Cashflow from Financing

-

-

-

-

-

-

-

-

-

Increase in Cash

€2,236,904

685.8%

-€381,849

-123.8%

€1,603,349

175.7%

-€2,117,329

-999.9%

-€138,416

 

Miscellaneous

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Contingent Liability

NO

-

NO

-

NO

-

NO

-

NO

Capital Employed

€16,154,151

12.7%

€14,336,565

6.3%

€13,489,250

-12.2%

€15,358,588

-30.3%

€22,033,691

Number of Employees

85

2.4%

83

-

83

3.8%

80

-

80

Auditors

KPMG

Auditor Comments

The audit report contains no adverse comments

Bankers

ULSTER BANK LTD

Bank Branch Code

98-63-04

 

Ratios

 

Date Of Accounts

31/12/12

31/12/11

31/12/10

31/12/09

31/12/08

Pre-tax profit margin %

6.23

3.02

2.42

3.19

5.89

Current ratio

1.81

2.77

2.39

2.16

2.65

Sales/Net Working Capital

4.41

4.59

4.92

3.41

3.44

Gearing %

1.90

2

2.10

1.80

0.90

Equity in %

60.10

76

73.70

68.80

76.40

Creditor Days

4.93

4.26

3.50

3.68

1.72

Debtor Days

42.81

39.85

41.39

49.98

11.60

Liquidity/Acid Test

1.42

2.27

1.90

1.73

2.36

Return On Capital Employed %

14.15

7.10

5.59

5.60

10.64

Return On Total Assets Employed %

8.66

5.51

4.17

3.87

8.07

Current Debt Ratio

0.64

0.29

0.34

0.45

0.32

Total Debt Ratio

0.66

0.31

0.36

0.47

0.32

Stock Turnover Ratio %

10.70

6.16

7.08

10.79

5.03

Return on Net Assets Employed %

14.42

7.24

5.70

5.70

10.73

 

FOREIGN EXCHANGE RATES

 

N/a

 

ADDITIONAL INFORMATION

 

Status History

 

No Status History found

 

Event History

 

Date

Description

11/12/2013

PRADEEP CHAUHAW has left the board

05/03/2013

New Accounts Filed

27/02/2013

Annual Returns

29/01/2013

New Board Member (NEERAJ SHARMA) appointed

20/12/2012

DEBASHIS DAS GUPTA has left the board

09/05/2012

New Accounts Filed

09/05/2012

New Accounts Filed

25/04/2012

Annual Returns

26/03/2012

New Board Member (VICKRAMAN SATTANTHAN) appointed

23/03/2012

SANDEEP MEHANDROO has left the board

05/03/2012

SANDEEP PURI has left the board

23/08/2011

New Accounts Filed

12/08/2011

Annual Returns

07/03/2011

ARUN SAWHNEY has left the board

07/03/2011

New Board Member (PRADEEP CHAUHAW) appointed

 

 

Previous Company Names

 

Date

Previous Name

N/A

RIMA PHARMACEUTICALS LIMITED

 

Received Documents

 

Statistics

 

Group

11 companies

Linkages

25 companies

Countries

In 8 countries

 

NOTES & COMMENTS

 

Commentary

 

No exact match CCJs are recorded against the company.

 

Sales in the latest trading period increased 8.7% on the previous trading period.

 

Net Worth increased by 12.8% during the latest trading period.

 

 

A 42.7% growth in Total Assets occurred during the latest trading period.

 

Pre-tax profits increased by 124.4% compared to the previous trading period.

 

The company saw an increase in their Cash Balance of 87.3% during the latest trading period.

 

The audit report contains no adverse comments.

 

The company has undergone recent changes in its directorships.

 

The company is part of a group.

 

The company was established over 33 years ago.

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 58.86

UK Pound

1

Rs. 98.82

Euro

1

Rs. 80.71

 

 

INFORMATION DETAILS

 

Analysis Done by :

KRN

 

 

Report Prepared by :

DPT

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.